| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.05. | KAZIA THERAPEUTICS LTD - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 01.05. | Kazia Therapeutics Limited: Kazia Reports Successful Stage 1 Completion Of The Evt801 Phase 1 Clinical Trial In Advanced Cancer Patients | 71 | PR Newswire | SYDNEY, May 1, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased to announce that the Safety Review Team (SRT) of the... ► Artikel lesen | |
| 19.04. | KAZIA THERAPEUTICS LTD - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 26.03. | KAZIA THERAPEUTICS LTD - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 21.03. | Kazia Therapeutics Limited: Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases | 110 | PR Newswire | SYDNEY, March 21, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased to announce that it has entered into an exclusive... ► Artikel lesen | |
| 21.02. | KAZIA THERAPEUTICS LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.02. | Kazia Therapeutics Limited: Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint | 375 | PR Newswire | Paxalisib plus Radiotherapy Data Shows Promise for Treating Patients with PI3K Pathway Mutation Brain Metastases
SYDNEY, Feb. 21, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA)... ► Artikel lesen | |
| 31.01. | KAZIA THERAPEUTICS LTD - F-1, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 18.01. | Kazia Therapeutics strengthens board with new appointments | 1 | Investing.com | ||
| 12.01. | KAZIA THERAPEUTICS LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 15.12.23 | Kazia Therapeutics files to sell 591,697 ADSs for holders | 3 | Seeking Alpha | ||
| 01.12.23 | Kazia Therapeutics falls after announcing $2M direct offering | 4 | Seeking Alpha | ||
| 01.12.23 | Kazia Therapeutics Announces Registered Direct Offering | 2 | RTTNews | ||
| 29.11.23 | KAZIA THERAPEUTICS LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.11.23 | Kazia Therapeutics Enters Non-binding LOI For Paxalisib Rights Outside Of Oncology | 3 | RTTNews | ||
| 20.11.23 | Kazia Therapeutics gets deficiency notice from Nasdaq | 2 | Seeking Alpha |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 7.335 |
| EVOTEC | 5.762 |
| TUI | 5.308 |
| PLUG POWER | 3.802 |
| NEL | 3.452 |
| AMC ENTERTAINMENT | 3.446 |
| BAYER | 2.682 |
| SIEMENS ENERGY | 2.487 |
| NVIDIA | 2.337 |
| RHEINMETALL | 2.325 |
| COMMERZBANK | 2.074 |
| AIXTRON SE | 1.821 |
| DEUTSCHE BANK | 1.796 |
| ALLIANZ | 1.720 |
| RWE | 1.653 |
| MERCEDES-BENZ | 1.612 |
| THYSSENKRUPP | 1.576 |
| BYD | 1.536 |
| THYSSENKRUPP NUCERA | 1.497 |
| SUPER MICRO COMPUTER | 1.453 |
| RENK GROUP | 1.443 |
| VOLKSWAGEN | 1.344 |
| NORDEX | 1.221 |
| ALIBABA | 1.216 |
| SIEMENS | 1.168 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
